ResearchMoz added Latest Research Report titled " MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts " to it's Large Report database.
MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts
Summary
Rheumatoid Arthritis (RA) is the commonest autoimmune disease in humans. The disease is prevalent in all ethnic groups, affecting approximately 1.0% of the world population. Presently there is a huge presence of unmet patient needs for both the treatment and diagnosis.
Focus for the treatment paradigm has now shifted towards the early detection and diagnosis of the disease, which will allow physicians to begin aggressive treatment of the condition, minimizing the associated complications and tissue damage.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=816386
Global sales of $347m in 2016 and estimated growth rate of 2% during the forecast period; the emerging markets: Brazil, Canada, China and Mexico are expected to show the fastest growth.
Key market drivers -
- Increasing prevalence of autoimmune diseases globally including RA
- Emerging biomarkers and advancement in technology for the early diagnosis of RA
- Increasing adoption of anti-cyclic citrullinated peptide (anti-CCP) antibody test
- Rising demand for lab automation
Key market barriers -
- Limited sensitivity of existing RA diagnostic tests
- Healthcare cost-cutting and reduced reimbursement in major markets
Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html
Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 Catalyst 16
2.2 Related Reports 17
3 Market Access 18
3.1 Rheumatoid Arthritis Testing Overview 18
3.2 Reimbursement Trends 20
3.2.1 North America 20
3.2.2 Europe 23
3.2.3 Asia-Pacific 24
3.2.4 South America 26
3.3 Mergers, Acquisitions, and Key Partnerships 28
4 Unmet Needs 29
4.1 Earlier Diagnosis 29
4.2 Seronegativity and Sensitivity 29
4.2.1 Rheumatoid Factor 29
4.2.2 Anti-Cyclic Citrullinated Peptide Antibody 30
4.2.3 14-3-3 30
4.3 Novel Biomarkers for Rheumatoid Arthritis Diagnosis 31
5 Competitive Assessment 32
5.1 Company Share Analysis 32
5.1.1 Global 32
5.2 Abbott Diagnostics 33
5.2.1 Overview 33
5.2.2 Marketed Products Assessment 34
5.2.3 SWOT Analysis 35
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts
Summary
Rheumatoid Arthritis (RA) is the commonest autoimmune disease in humans. The disease is prevalent in all ethnic groups, affecting approximately 1.0% of the world population. Presently there is a huge presence of unmet patient needs for both the treatment and diagnosis.
Focus for the treatment paradigm has now shifted towards the early detection and diagnosis of the disease, which will allow physicians to begin aggressive treatment of the condition, minimizing the associated complications and tissue damage.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=816386
Global sales of $347m in 2016 and estimated growth rate of 2% during the forecast period; the emerging markets: Brazil, Canada, China and Mexico are expected to show the fastest growth.
Key market drivers -
- Increasing prevalence of autoimmune diseases globally including RA
- Emerging biomarkers and advancement in technology for the early diagnosis of RA
- Increasing adoption of anti-cyclic citrullinated peptide (anti-CCP) antibody test
- Rising demand for lab automation
Key market barriers -
- Limited sensitivity of existing RA diagnostic tests
- Healthcare cost-cutting and reduced reimbursement in major markets
Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html
Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 Catalyst 16
2.2 Related Reports 17
3 Market Access 18
3.1 Rheumatoid Arthritis Testing Overview 18
3.2 Reimbursement Trends 20
3.2.1 North America 20
3.2.2 Europe 23
3.2.3 Asia-Pacific 24
3.2.4 South America 26
3.3 Mergers, Acquisitions, and Key Partnerships 28
4 Unmet Needs 29
4.1 Earlier Diagnosis 29
4.2 Seronegativity and Sensitivity 29
4.2.1 Rheumatoid Factor 29
4.2.2 Anti-Cyclic Citrullinated Peptide Antibody 30
4.2.3 14-3-3 30
4.3 Novel Biomarkers for Rheumatoid Arthritis Diagnosis 31
5 Competitive Assessment 32
5.1 Company Share Analysis 32
5.1.1 Global 32
5.2 Abbott Diagnostics 33
5.2.1 Overview 33
5.2.2 Marketed Products Assessment 34
5.2.3 SWOT Analysis 35
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
No comments:
Post a Comment